Get the Stockscreener App
2.50
1.21%
0.03
After Hours:
2.48
-0.02
-0.80%
Profusa Inc stock is traded at $2.50, with a volume of 198.77K.
It is up +1.21% in the last 24 hours and down -33.44% over the past month.
Profusa Inc is a clinical-stage digital health and medical technology company. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. The Lumee Oxygen Platform has been designed for use in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds that do not heal properly; and reconstructive surgery.
See More
Previous Close:
$2.47
Open:
$2.52
24h Volume:
198.77K
Relative Volume:
0.13
Market Cap:
$1.51M
Revenue:
$75,000
Net Income/Loss:
$-42.41M
P/E Ratio:
-0.0139
EPS:
-179.8206
Net Cash Flow:
$-18.47M
1W Performance:
-4.58%
1M Performance:
-33.44%
6M Performance:
-27.32%
1Y Performance:
-96.86%
1-Day Range:
$2.37
$2.65
1-Week Range:
$2.37
$2.98
52-Week Range:
$0.3204
$180.00
Profusa Inc Stock (PFSA) Company Profile
Name
Profusa Inc
Sector
Industry
Phone
212-494-9022
Address
207 WEST 25TH ST, 9TH FLOOR, NEW YORK
Compare PFSA vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PFSA
Profusa Inc
|
2.50 | 1.50M | 75,000 | -42.41M | -18.47M | -179.82 |
ABT
Abbott Laboratories
|
103.36 | 182.09B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
91.62 | 117.54B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
270.01 | 105.63B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.10 | 65.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.77 | 49.67B | 6.30B | 1.07B | 1.09B | 1.8406 |
Profusa Inc Stock (PFSA) Latest News
This Biotech Stock Crashed 28% Today After Announcing Second Reverse Share Split This Year - Stocktwits
Profusa, Inc. Common Stock (NASDAQ: PFSA) Share Price, PFSA Stock News, PFSA Share Price & Updates - Kalkine
Profusa CEO Jack E. Stover Reports Zero Shares Held Following Two $0 Transactions on August 21, 2026 - Kalkine Media
Profusa (PFSA) CFO shifts stake from sponsor to direct - Stock Titan
Profusa (PFSA) CEO restructures 334K-share holding - Stock Titan
PROFUSA INC (PFSA) Stock Chart - ChartMill
Profusa Issues $329,670 Senior Secured Convertible Note to Ascent; $300,000 Proceeds, 7% Interest - TradingView
Profusa Announces September 18 Virtual Special Meeting to Approve Reverse Stock Split Plan - Kalkine Media
Profusa regains compliance with Nasdaq listing requirements By Investing.com - Investing.com Canada
Profusa Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Profusa regains compliance with Nasdaq listing requirements - Investing.com
Profusa Regains Nasdaq Compliance for Publicly Held Shares Requirement - Minichart
Profusa Receives Nasdaq Notice on Publicly Held Shares Requirement, Compliance Confirmed and Review Closed - Quiver Quantitative
Profusa, Inc. Announces Compliance with Nasdaq Publicly Held Shares Requirement - Yahoo Finance
HRT Financial LP Reduces Stake in Profusa Inc (PFSA) Amid Deteriorating Fundamentals - GuruFocus
Profusa amends financing deal, resets debt conversion price at $1.07 per share - Bitget
Profusa Raises $714K Via Convertible Note, Moves to Exchange $6.14M Debt for Preferred With Ascent - TradingView
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Profusa net hits USD 8.8M in Q2 2026 - Medical Buyer
Profusa shares drop 28% amid Q2 loss, reverse s... - Pluang
Profusa Announces Q2 2026 Financial Results a - Moomoo
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Profusa Advances G3 Vision Labs Acquisition Conditions as Q2 Net Loss Widens - Yahoo Finance
Profusa converts $4.6M debt to preferred stock ahead of G3 deal - Investing.com Australia
Profusa Reports Q2 Net Loss Widens to $8.8M Amid G3 Option Deal Progress - Minichart
Profusa reports Q2 2026 net loss of $8.8M; stockholders’ equity expected $28.4M after option agreement - TradingView
Profusa Announces Q2 2026 Financial Results and Progress on the Option Agreement Conditions to Close with G3 Vision Labs, a Commercial Stage Diagnostics Company - marketscreener.com
Profusa Announces Q2 2026 Financial Results and Progress on - GlobeNewswire
symbol__ Stock Quote Price and Forecast - CNN
Profusa Company Profile & Introduction - Moomoo
Profusa (PFSA) CFO converts $1.29M note into 302K shares at $4.28 - Stock Titan
Profusa (PFSA) sponsor’s $1.3M debt swap nears half the stock - Stock Titan
Profusa (PFSA) CEO turns $1.29M note into 301,991 shares - Stock Titan
NorthView Sponsor I, LLC Discloses Investment at Profusa, Inc. with 49.9% Stake - TradingView
Profusa Cash Drops to $719K, Digital Assets Eliminated - Minichart
Profusa, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
HRT Financial LP sells $109,266 of Profusa stock By Investing.com - Investing.com Nigeria
HRT Financial LP sells $109,266 of Profusa stock - Investing.com
Profusa (PFSA) 10% holder cuts direct stake to zero - Stock Titan
Mercury Systems Posts Mixed Q4 Results, Joins WhiteFiber And Other Big Stocks Moving Lower In Wednesday’s - Benzinga
Nasdaq Down Over 1%; Home Depot Earnings Top Estimates - Sahm
Profusa announces special shareholder meeting - Bitget
Profusa Stock Fall 35% After Hours Following 500% Intraday SurgeProfusa (NASDAQ:PFSA) - Benzinga
Profusa Stock Dips After Hours As Whopping 506% Rally Cools: Here Is Why PFSA Is Trending - TradingView
Profusa, Baidu, Amylyx Pharmaceuticals, FreeCast and Klarna Group: Why These 5 Stocks Are on Investors' R - Benzinga
Profusa, Baidu, Amylyx Pharmaceuticals, FreeCast and Klarna Group: Why These 5 Stocks Are on Investors' Radars Today - TradingView
Profusa (NASDAQ: PFSA) 10% owner sells 3,163 shares - Stock Titan
Profusa (PFSA) Share-Price Review: Gains 179.25% to Reach $12.65; Level Position: the Session Ends Within the Reported Technical Boundaries in the Latest ReadingUp Down Volume - vinanet.vn
Trending Stocks Today | Profusa Soars 251.65% - Moomoo
Profusa (PFSA) Stock Sinks After Diagnostics Deal News - timothysykes.com
Profusa Inc Stock (PFSA) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.29%
0.75%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):